Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lung Cancer
Genes Explain Better Japanese Lung Cancer Drug Results
June 18th, 2007
Last year, a groundbreaking international project found that a group of Japanese patients with advanced non-small cell lung cancer survived longer —and had a higher rate of side effects — than U.S. patients with the same diagnosis, when both groups were given two well-known drugs for the disease. Now, a follow-up study suggests the reasons appear to lie in subtle variations in certain genes that govern how the body metabolizes chemotherapy drugs. David Gandara, M.D., a University of California, Davis researcher who led the recent Southwest Oncology Group study, will present the results Saturday, June 2, at the American Society of Clinical Oncology annual meeting. ...
Source: Health & Medicine Week (2007-06-18)
|
